Guy Beauchamp

The Wellcome Trust Ltd. engages welfare and charitable services. It supports the discovery of vaccines and drug-resistant infections, diversity and inclusion, open research, government investment in research, data sharing in public health emergencies, and strengthening ecosystems. The company was founded by Henry Wellcome in 1936 and is headquartered in London, UK.

ProterixBio, Inc. supplies novel protein measurement technology. It manufactures and markets the ViBE platform, enabling highly sensitive, automated acoustic immunoassays to accelerate drug discovery, development and production of biological and pharmaceutical products. The company was founded by Edward F. Crawley and Mark Lundstrom in 2002 and is headquartered in Billerica, MA.

Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC.

Ionix Pharmaceuticals Ltd. used to develop analgesic medicines for the treatment of acute and chronic pain. Its drugs were used for the treatment of pain associated with chronic debilitating diseases such as osteoarthritis, diabetes, cancer and multiple sclerosis. The company was founded by Andrew Sandham, Phillip J. Birch, John Wood and Ann Gail Hayes in 2001 and was located in Cambridge, UK.

TheraSci Ltd. provides health supplements for doctors, healthcare practitioners, and medical professionals. The private company is based in Cambridge, UK and was founded by Ann Gail Hayes. The British company's products include supplements for cardiometabolic, gastrointestinal, immune health, pain, hormone support, stress, sleep support, general wellness, and body composition. TheraSci aims to provide a high-quality nutraceutical sales and service platform that streamlines the product purchase and delivery process, while minimizing impact on physician workflow and optimizing patient health outcomes.

Pulmagen Therapeutics (Synergy) Ltd. develops therapeutics for respiratory diseases. It engages in developing various internal proprietary programs in chronic obstructive pulmonary disease, asthma, and cystic fibrosis. The company was founded in August 2000 and is headquartered in Stevenage, the United Kingdom.

ApaTech Ltd. develops synthetic bone graft technology. It specializes in producing synthetic bone repair material. The company has developed a novel silicate substituted calcium phosphate bone graft material, Actifuse, which underpins the company's leadership in applying the science of silicon to bone graft technologies. Actifuse is the first of a new class of synthetic bone graft materials that combine osteoconductive, osteostimulatory and bioactive qualities resulting in accelerated bone growth. The company was founded in 2001 and is headquartered in Elstree, UK.

ReNeuron Ltd. researches and develops drugs, diagnostics, and other therapeutic products. The company was founded on May 23, 1997 and is headquartered in Bridgend, the United Kingdom.

Molten Ventures (Private Equity) (Molten Ventures) is a venture capital firm subsidiary of Molten Ventures Plc founded in 1998 by Simon Christopher Cook and Stuart Malcolm Chapman. The firm is headquartered in London, United Kingdom.

Touchstone Innovations Investment Management Ltd. is a Venture Capital firm, a subsidiary of Touchstone Innovations Ltd. founded in 1986. Touchstone Innovations Investment Management Ltd. is headquartered in London.

Celentyx Ltd. provides research and development on human immune disease. The firm's services include rapid analysis screening of drug action on physiological and pathological human immune tissues and cells. It provides services by disease, cell type, assay through its ImmuKnowlogy platform technology. The company was founded by Nicholas Mark Barnes and John Gordon in 2004 and is headquartered in Birmingham, the United Kingdom.

Psynova Neurotech Ltd. provides commercial development and exploitation of novel biomarkers for Neuropsychiatric and other mental illnesses. The company was founded by Sabine Bahn on August 1, 2005 and is headquartered in Cambridge, the United Kingdom.

Part of Otsuka Holdings Co., Ltd., Veryan Holdings Ltd. is a holding British company that provides research and development services for clinical trials of novel vascular devices. The company is based in Oxford, UK and was founded in 2007.

Endomagnetics Ltd. develops surgical instruments used in the treatment of cancer. It offers SentiMag, a surgical instrument for use in the treatment of breast cancer and melanoma by helping surgeons to identify the sentinel lymph node for excision and subsequent histology to determine whether cancer has spread from a nearby tumor site. The company was founded by Quentin Pankhurst, Simon Hattersley, and Audrius Brazdeikis in April 2007 and is headquartered in Cambridge, the United Kingdom.

Puridify Ltd. develops bioprocessing technologies. It develops a platform purification technology that will improve processing opportunities and reduce costs. The company was founded by Oliver Hardick, Iwan Thomas Roberts and Thomas Edward Haywood in 2013 and is headquartered in Stevenage, the United Kingdom.

Fluidic Analytics Ltd. develops proprietary technology to characterize proteins. The company was founded by Tuomas Knowles in 2013 and is headquartered in Cambridge, the United Kingdom.

EcoEos, Inc. provides environmental genetic testing services. The company is based in San Francisco, CA. The company was founded by Gregory Stock, David Ewing Duncan, Lisa A. Conte. Gregory Stock has been the CEO since incorporation.

Push Dr. Ltd. provides NHS-commissioned online service connecting patients with a network. The company was founded in 2013 by Eren Ozagir and is headquartered West Midlands, the United Kingdom.

Oxular Ltd. engages in research and experimental development on biotechnology. The firm develops retinal treatments to access specific small spaces in the eye and to provide drug distribution to tissues involved in retinal diseases. The company was founded by Tom Cavanagh and Ronald K. Yamamoto in 2014 and is headquartered in Oxford, the United Kingdom.

Lifesum AB operates a platform that helps make better food choices and improve exercise and reach health goals. Its application combines technology and applied psychology with personal preferences. The company was founded by Tove Westlund, Martin Wahlby, Henrik Torstensson and Marcus Gners in 2008 and is headquartered in Stockholm, Sweden.

Mimi Hearing Technologies GmbH engages in the development of hearing enhancement technology and tools for smart phones. It offers Mimi.io, an application that allows users to perform hearing test, try different hearing enhancement profiles, and experience the difficulties associated with hearing loss. The company was founded by Nick Clark, Philipp Skribanowitz, and Pascal Werner in 2014 and is headquartered in Berlin, Germany.

MatOrtho Ltd. specializes in developing orthopedic medical devices. The company is based in Leatherhead, UK and was founded in 2010 by Mike Tuke. The British company's adept® hip resurfacing system has been in successful clinical use for over 16 years, and they also manufacture the mrk™, which is the original 1994 ‘ medial ball-and-socket knee ’ that remains in popular use.

ApcinteX Ltd. develops and markets anticoagulant APC pathway to treat haemophilia. The company is headquartered in London, the United Kingdom.

NuvoAir AB provides health care sevices. Its devices include air smart spirometer and disposable turbines. The company was founded by Lorenzo Consoli and is headquartered in Stockholm, Sweden.

Kheiron Medical Technologies Ltd. develops learning powered tools to help radiologists, radiology departments, imaging centers and hospitals. The company was founded by Peter Daniel Kecskemethy and Tobias Rijken in 2016 and is headquartered in London, the United Kingdom.

Evonetix Ltd. is a biotechnology company. The firm offers pharmaceuticals and drug discovery, industrial biotech and renewables, materials science, agriculture, digital data storage, and food and beverages. The company was founded by Hermann Maria Hauser and Joseph Brennan in 2015 and is headquartered in Little Chesterford, the United Kingdom.

Pelago operates as a subset of digital health. It specializes in health discipline and treatment option that utilizes digital and often online health technologies to treat a medical or psychological condition. The company was founded by Yusuf Sherwani, Sarim Siddiqui and Maroof Ahmed in 2016 and is headquartered in London, the United Kingdom.

Oxford VR Ltd. provides clinical psychological science for mental health through technology. The company was founded by Daniel Freeman and is headquartered in Oxford, the United Kingdom.

Closed Loop Medicine Ltd. operates as a new breed of therapeutics company focused on care pathways, outcomes and the provision of dynamic personalised regimens. It combines proven drugs with digital therapeutics enabling the digitisation and data capture of an entire care continuum. The company was founded by Felicity Sartain, Hakim Yadi, Paul Goldsmith, and David Cox in 2017 and is headquartered in London, the United Kingdom.

Part of Access Technology Group Ltd., Alcuris Ltd. is a British company that researches and develops technological solutions for the healthcare industry. The company is based in Loughborough, UK. Alcuris was acquired by Access UK Ltd. on November 18, 2021. The company was founded by Alexander Nash. Alexander Nash has been the CEO since incorporation.

Arctoris Ltd. is a British tech-enabled biopharma platform company that combines robotics and machine learning with a world-class team for accelerated small molecule discovery. The company is based in Oxford, UK, with its operations also located in the same city. Arctoris' unique technology platform, Ulysses, enables the company and its partners to conduct their R&D significantly faster, with improved data quality and depth. Arctoris progresses a pipeline of wholly-owned and partnered first-in-class and best-in-class therapeutics in oncology and neurodegeneration. The company was founded in 2016 by Martin-Immanuel Bittner and Thomas A. Fleming, with Martin-Immanuel Bittner serving as the CEO since then.

Axis Spine Technologies Ltd. engages in experimental development on natural sciences and engineering. The company is headquartered in Hertfordshire, the United Kingdom.

Healthily By Your Md provides a self-care app designed to assist individuals in managing their health.

Zoe Ltd. is a British women-owned company that has been designing semi-custom party wear dresses for over 35 years. Zoe is based in London, UK. The company's design team works one-on-one with customers to create gorgeous gowns for any occasion. The company offers a collection of trendy dresses for girls aged 4 to 16, characterized by intricate designs with luxury fabrics. Customers can shop their collection online and purchase items directly from stores. Extra fabric and additional sizes are available upon request. The company was founded in 2017.

Veryan Medical Ltd. develops and commercializes novel vascular stent technology. The firm's products are designed to clinical performance and bio-mechanical performance of stented vessels. The company was founded by Colin G. Caro, Charles Richard Taylor and Paul Burke Gilson in 2003 and is headquartered in Oxford, the United Kingdom.

Horizon Discovery Ltd. develops and supplying patient-relevant drug discovery and diagnostic research tools. The frm also supplies genetically-defined cell lines, reporter gene assay kits, genomic reference standards and contract research services to organizations engaged in bio-pharmaceutical process optimization, drug discovery & development, and clinical diagnostic development. The company was founded by Christopher John Torrance and Alberto Bardelli on February 14, 2005 and is headquartered in Cambridge, the United Kingdom.

Inivata Ltd. develops new clinical applications for ctDNA analysis. It is a clinical cancer genomics company harnessing the potential of circulating tumour DNA (ctDNA) analysis to improve cancer testing and treatment. The firm is focused on developing clinical applications of ctDNA through collaborations with clinical oncologists at prominent academic institutions, leading community treatment centres and innovative biopharmaceutical companies. The company was founded by James Brenton, Tim Forshew, Rosenfeld Nitzan and Davina Gale on July 23, 2014 and is headquartered in Cambridge, the United Kingdom.